Solute strengthening of twinning dislocations in Mg alloys

Solute strengthening of twin dislocation motion along an existing twin boundary in Mg–X (X = Al, Zn) is investigated using a new Labusch-type weak pinning model. First, the View the MathML source(101¯2) twinning dislocation structure is computed using first-principles methods. Second, the interaction energies of Al and Zn solutes with the twin boundary and twin dislocation are computed. It is shown that the interaction energies of Zn solutes scale with the Al solute energies in proportion to the misfit volume plus an additional “chemical” interaction factor, demonstrating an efficient means for estimating the solute energies of other solutes. Third, the solute–dislocation interaction energies are used in a new Labusch-type model to predict the overall solute strengthening of the twinning dislocation. New features emerge in the application of the model to twinning because of the very small Burgers vector of the twin dislocation, leading to a new functional form for the dependence of the strengthening on concentration, temperature and strain rate. Fourth, application of the model leads to parameter-free predictions that agree well with available experimental data on various Mg–Al–Zn alloys. The predicted strengthening is not large, e.g. ≈10≈10 MPa for the AZ31 alloy at room temperature, but is larger than the strengthening of basal slip by the same solutes. Overall, this work demonstrates the ability of mechanistic theories to provide a quantitative understanding of alloying effects on deformation modes in Mg

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362

Thermomechanics of the cooling stage in casting processes: Three-dimensional finite element analysis and experimental validation

International audienceA thermomechanical three-dimensional (3-D) finite element analysis of solidification is presented. The heat transfer model is based on a multidomain analysis accounting for noncoincident meshes for the cast part and the different mold components. In each subdomain, a preconditioned conjugate gradient solver is used. The mechanical analysis assumes the mold is rigid. A thermoelastic-viscoplastic rheological model is used to compute the constrained shrinkage of the part, resulting in an effective local air gap width computation. At each time increment, a weak coupling of the heat transfer and mechanical analyses is performed. Comparisons of experimental measurements and model predictions are given in the case of a hollow cylindrical aluminum alloy part, showing a good quantitative agreement. An application to an industrial aluminum casting is presented, illustrating the practical interest of thermomechanical computations in solidification analysis

International Nosocomial Infection Control Consortium report, data summary of 50 countries for 2010-2015: Device-associated module

•We report INICC device-associated module data of 50 countries from 2010-2015.•We collected prospective data from 861,284 patients in 703 ICUs for 3,506,562 days.•DA-HAI rates and bacterial resistance were higher in the INICC ICUs than in CDC-NHSN's.•Device utilization ratio in the INICC ICUs was similar to CDC-NHSN's. Background: We report the results of International Nosocomial Infection Control Consortium (INICC) surveillance study from January 2010-December 2015 in 703 intensive care units (ICUs) in Latin America, Europe, Eastern Mediterranean, Southeast Asia, and Western Pacific. Methods: During the 6-year study period, using Centers for Disease Control and Prevention National Healthcare Safety Network (CDC-NHSN) definitions for device-associated health care-associated infection (DA-HAI), we collected prospective data from 861,284 patients hospitalized in INICC hospital ICUs for an aggregate of 3,506,562 days. Results: Although device use in INICC ICUs was similar to that reported from CDC-NHSN ICUs, DA-HAI rates were higher in the INICC ICUs: in the INICC medical-surgical ICUs, the pooled rate of central line-associated bloodstream infection, 4.1 per 1,000 central line-days, was nearly 5-fold higher than the 0.8 per 1,000 central line-days reported from comparable US ICUs, the overall rate of ventilator-associated pneumonia was also higher, 13.1 versus 0.9 per 1,000 ventilator-days, as was the rate of catheter-associated urinary tract infection, 5.07 versus 1.7 per 1,000 catheter-days. From blood cultures samples, frequencies of resistance of Pseudomonas isolates to amikacin (29.87% vs 10%) and to imipenem (44.3% vs 26.1%), and of Klebsiella pneumoniae isolates to ceftazidime (73.2% vs 28.8%) and to imipenem (43.27% vs 12.8%) were also higher in the INICC ICUs compared with CDC-NHSN ICUs. Conclusions: Although DA-HAIs in INICC ICU patients continue to be higher than the rates reported in CDC-NSHN ICUs representing the developed world, we have observed a significant trend toward the reduction of DA-HAI rates in INICC ICUs as shown in each international report. It is INICC's main goal to continue facilitating education, training, and basic and cost-effective tools and resources, such as standardized forms and an online platform, to tackle this problem effectively and systematically